The moral of the story, therapeutics for Covid 19 are here to stay, long after all the dust settles for people that get vaccinated and for the ones that simply don't want to be.
Resverlogox needs to attend to this ASAP. After all, Don has said it's not all that expensive and can be accomplished in a very short time frame.
Note: bodes well for RVX.WT.A, 2023, share purchase warrants.
Koo